Notify me when Richard A. Miller files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| CRVS | Corvus Pharmaceuticals, Inc. | Common Stock, $0.0001 par value per share | 7.7% | $15.2M | 5.22M | Richard A. Miller | Dec 31, 2024 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Date Filed |
|---|